glp 1 and family history of thyroid cancer There is no conclusive evidence linking GLP-1 medications to in the general population. But for people with certain rare syndromes the risk picture is different, which is why these Glucagon‐like peptide‐1 receptor agonists and

Ganju and coauthors commented, Defining the role of GLP-1 RAs in Crohns disease is critical as obesity prevalence rises and integrated care models across gastroenterology, endocrinology, and obesity medicine become more essential. This study included 546 patients with CD with overweight or obesity who had initiated use of a GLP-1RA and were matched with 546 nonGLP-1RA users from the TriNetX research network

Originally developed for type 2 diabetes, these drugs have now proven to be some of the most powerful tools for sustainable weight loss

For many years, the GLP-1 drug market was dominated by injectable therapies such as Semaglutide and Tirzepatide

After enrolling, Harris received initial orders

A mislabeled retatrutide vial could lead to a massive overdose, causing severe nausea, vomiting, or permanent metabolic damage

As more patients are started on GLP-1 analogues, optometrists should be aware of the frequency of potential worsening retinopathy that occurs with rapid, improved glycemic control